Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genes and Diseases is Scopus-indexed (Q1, CiteScore 10.4), WoS SCIE, DOAJ. Published by KeAi Communications Co..
Checked against the index lists dated .
ISSN 2352-3042Verify ISSN ↗2352-4820Verify ISSN ↗
Publisher: KeAi Communications Co.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 7 / 100 | 93rd | Q1 |
| Biochemistry | 56 / 448 | 87th | Q1 |
| Molecular Biology | 62 / 414 | 85th | Q1 |
| Cell Biology | 53 / 289 | 81st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 10.4.
Genes and Diseases is Q1 in Genetics (clinical) (rank 7 of 100), Q1 in Biochemistry (rank 56 of 448) and Q1 in Molecular Biology (rank 62 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
Genes and Diseases is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.4, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.776, quartile Q1, with an H-index of 77.
The publisher lists an article processing charge of about US$2,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Genes and Diseases is published by KeAi Communications Co. Its print ISSN is 2352-3042 and its online ISSN is 2352-4820.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Genes and Diseases has an h-index of 91 and a 2-year mean of 2.1 citations per paper (OpenAlex). Its Scopus CiteScore is 10.4, quartile Q1. On 2-year citations it ranks #48 of 99 Scopus journals in Genetics (clinical).
Genes and Diseases published 453 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 87 research articles (2026), authors are most often from China (76.1%), United States (9.2%) and South Korea (4.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.